SARS-COV-2 vaccine responses in renal patient populations

SARS-COV-2 vaccine responses in renal patient populations

Abstract Background Dialysis patients and immunosuppressed renal patients are at increased risk of COVID-19 and were excluded from vaccine trials. We conducted a prospective multicentre study to assess SARS-CoV-2 vaccine antibody responses in dialysis patients and renal transplant recipients, and pa...

Full description

Bibliographic Details
Main Authors: Rona M. Smith, Daniel J. Cooper, Rainer Doffinger, Hannah Stacey, Abdulrahman Al-Mohammad, Ian Goodfellow, Stephen Baker, Sara Lear, Myra Hosmilo, Nicholas Pritchard, Nicholas Torpey, David Jayne, Vivien Yiu, Anil Chalisey, Jacinta Lee, Enric Vilnar, Chee Kay Cheung, Rachel B. Jones
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Nephrology
Subjects:
Vaccine
SARS-CoV-2
Immunosuppression
Rituximab
Mycophenolate
Transplant
Online Access:https://doi.org/10.1186/s12882-022-02792-w

Internet

https://doi.org/10.1186/s12882-022-02792-w

Similar Items